Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | GSK | ARGX | ||
| Company | Alexion Pharm Inc | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 181.04 | 37.03 | 596.39 | ||
| High | 182.67 | 37.26 | 597.21 | ||
| Low | 180.13 | 36.96 | 582.44 | ||
| Last | 182.50 | 37.06 | 587.71 | ||
| Change | +3.05 | +0.18 | -7.87 | ||
| % Change | +1.70% | +0.49% | -1.32% | ||
| Volume | 90,506,096 | 2,324,437 | 135,588 | ||
| 20-Day Average Volume | 8,395,359 | 6,340,154 | 232,692 | ||
| Previous Close | 179.45 | 36.88 | 595.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 38.21 | 553.54 | ||
| 20-Day Raw Stochastic | 44.63% | 16.93% | 73.79% | ||
| 20-Day Relative Strength | 55.14% | 36.95% | 62.37% | ||
| Weighted Alpha | +62.81 | -1.08 | +37.48 | ||
| Today's Opinion | 72% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | -2.22% since 10/28/24 | +5.62% since 10/28/24 | ||
| Low | 178.51 on 07/19/21 | 36.07 on 10/31/24 | 545.55 on 10/30/24 | ||
| High | 187.45 on 07/14/21 | 38.26 on 10/29/24 | 610.73 on 11/01/24 | ||
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | -4.59% since 10/04/24 | +10.50% since 10/04/24 | ||
| Low | 178.51 on 07/19/21 | 36.07 on 10/31/24 | 514.92 on 10/09/24 | ||
| High | 187.45 on 07/14/21 | 41.80 on 10/09/24 | 610.73 on 11/01/24 | ||
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -8.36% since 08/02/24 | +17.20% since 08/02/24 | ||
| Low | 164.83 on 04/29/21 | 36.07 on 10/31/24 | 475.65 on 08/05/24 | ||
| High | 187.45 on 07/14/21 | 44.67 on 08/27/24 | 610.73 on 11/01/24 | ||
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | -14.85% since 05/03/24 | +50.86% since 05/03/24 | ||
| Low | 146.97 on 03/04/21 | 36.07 on 10/31/24 | 352.77 on 05/14/24 | ||
| High | 187.45 on 07/14/21 | 45.92 on 05/15/24 | 610.73 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 76,435,424 | 35,613,304 | ||
| Shares Outstanding, K | 221,019 | 2,072,544 | 59,796 | ||
| Annual Sales | 6,069,900,000 | 37,725,000,000 | 1,268,590,000 | ||
| Annual Net Income | 603,400,000 | 6,129,940,000 | -295,050,000 | ||
| Last Quarter Sales | 1,636,500,000 | 9,950,400,000 | 489,430,000 | ||
| Last Quarter Net Income | 636,000,000 | 1,480,440,000 | 29,070,000 | ||
| 60-Month Beta | 1.25 | 0.66 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 1.27 on 10/30/24 | 0.45 on 07/25/24 | ||
| Latest Earnings Date | 07/29/21 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | 0.385 on 08/16/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 8.82 | 0.00 | ||